Discovery of Metabolomics Biomarkers for Early Detection of Nephrotoxicity
暂无分享,去创建一个
Abraham Nyska | M. Mitchell | A. Nyska | K. Boudonck | L. Német | Lilla Keresztes | D. Shinar | M. Rosenstock | Kurt J. Boudonck | Matthew W. Mitchell | László Német | Lilla Keresztes | Doron Shinar | Moti Rosenstock
[1] Wei-Yin Loh,et al. Classification and regression trees , 2011, WIREs Data Mining Knowl. Discov..
[2] Ally Perlina,et al. Integrated pathway analysis of rat urine metabolic profiles and kidney transcriptomic profiles to elucidate the systems toxicology of model nephrotoxicants. , 2008, Chemical Research in Toxicology.
[3] P. Devarajan. Proteomics for the investigation of acute kidney injury. , 2008, Contributions to nephrology.
[4] M. Milburn,et al. Analysis of the adult human plasma metabolome. , 2008, Pharmacogenomics.
[5] Xin Lu,et al. Serum metabonomics study of chronic renal failure by ultra performance liquid chromatography coupled with Q-TOF mass spectrometry , 2008, Metabolomics.
[6] Elaine Holmes,et al. Prediction and classification of drug toxicity using probabilistic modeling of temporal metabolic data: the consortium on metabonomic toxicology screening approach. , 2007, Journal of proteome research.
[7] N. Serkova,et al. Biochemical mechanisms of nephrotoxicity: application for metabolomics , 2007 .
[8] H. Wallace,et al. Polyamine analogues – an update , 2007, Amino Acids.
[9] Yan Ni,et al. Metabolic profiling using combined GC–MS and LC–MS provides a systems understanding of aristolochic acid‐induced nephrotoxicity in rat , 2007, FEBS letters.
[10] N. Serkova,et al. Biochemical mechanisms of nephrotoxicity: application for metabolomics. , 2007, Expert opinion on drug metabolism & toxicology.
[11] Y. Dragan,et al. Evaluation of NMR spectral data of urine in conjunction with measured clinical chemistry and histopathology parameters to assess the effects of liver and kidney toxicants , 2007, Metabolomics.
[12] P. Kubler,et al. Aminoglycoside-associated Fanconi syndrome. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[13] C. Cass,et al. Renal nucleoside transporters: physiological and clinical implications. , 2006, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[14] Götz Schlotterbeck,et al. Application of metabonomics in a compound ranking study in early drug development revealing drug-induced excretion of choline into urine. , 2006, Chemical research in toxicology.
[15] J. Megyesi,et al. Metabolomic study of cisplatin-induced nephrotoxicity. , 2006, Kidney international.
[16] K. Kashiwagi,et al. Polyamines in renal failure , 2006, Amino Acids.
[17] J. Kramer,et al. Genomic-based biomarkers of drug-induced nephrotoxicity , 2006, Expert opinion on drug metabolism & toxicology.
[18] N. Seiler,et al. Polyamines and apoptosis , 2005, Journal of Cellular and Molecular Medicine.
[19] Cynthia A Afshari,et al. Prediction of Nephrotoxicant Action and Identification of Candidate Toxicity-Related Biomarkers , 2005, Toxicologic pathology.
[20] F. Westwood,et al. Metabonomics with 1H-NMR spectroscopy and liquid chromatography-mass spectrometry applied to the investigation of metabolic changes caused by gentamicin-induced nephrotoxicity in the rat , 2005, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.
[21] Stephen M Hewitt,et al. Discovery of protein biomarkers for renal diseases. , 2004, Journal of the American Society of Nephrology : JASN.
[22] Timothy A Bertram,et al. Identification of putative gene based markers of renal toxicity. , 2004, Environmental health perspectives.
[23] C. Dejong,et al. Renal metabolism of amino acids: its role in interorgan amino acid exchange. , 2004, The American journal of clinical nutrition.
[24] K. Thompson,et al. Overview on the application of transcription profiling using selected nephrotoxicants for toxicology assessment. , 2004, Environmental health perspectives.
[25] Leo Breiman,et al. Random Forests , 2001, Machine Learning.
[26] John D. Storey,et al. Statistical significance for genomewide studies , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[27] J. McGill,et al. Serum 1,5-anhydroglucitol (GlycoMark ): a short-term glycemic marker. , 2003, Diabetes technology & therapeutics.
[28] M. Kosch,et al. Folate metabolism in renal failure. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[29] J. Griffin,et al. Metabolic profiling of chronic cadmium exposure in the rat. , 2001, Chemical research in toxicology.
[30] E Holmes,et al. Chemometric models for toxicity classification based on NMR spectra of biofluids. , 2000, Chemical research in toxicology.
[31] J. Lindon,et al. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. , 1999, Xenobiotica; the fate of foreign compounds in biological systems.
[32] W. Bennett,et al. Drug nephrotoxicity: an overview. , 1997, Renal failure.
[33] R. Nayar,et al. Nephrotoxicity of xenobiotics. , 1995, Clinica chimica acta; international journal of clinical chemistry.
[34] Y. H. Kim,et al. Effect of cisplatin on renal function in rabbits: mechanism of reduced glucose reabsorption. , 1995, Toxicology and Applied Pharmacology.
[35] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[36] J C Lindon,et al. Pattern recognition classification of the site of nephrotoxicity based on metabolic data derived from proton nuclear magnetic resonance spectra of urine. , 1994, Molecular pharmacology.
[37] C. Duarte,et al. Assessment of renal function--glomerular and tubular. , 1993, Clinics in laboratory medicine.
[38] J. Takala,et al. Urinary excretion of polyamines in patients with surgical and accidental trauma: effect of total parenteral nutrition. , 1993, Metabolism: clinical and experimental.
[39] M. Moscarello,et al. Aminoaciduria is an earlier index of renal tubular damage than conventional renal disease markers in the gentamicin-rat model of acute renal failure. , 1991, Clinical and investigative medicine. Medecine clinique et experimentale.
[40] C. K. Mcallister,et al. The Absence of Nephrotoxicity and Differential Nephrotoxicity Between Tobramycin and Gentamicin , 1990, Southern medical journal.
[41] M. Jeevanandam,et al. Polyamine levels as biomarkers of injury response in polytrauma victims. , 1989, Metabolism: clinical and experimental.
[42] J. Nicholson,et al. Investigations into the biochemical effects of region-specific nephrotoxins. , 1989, Molecular pharmacology.
[43] W. Bennett,et al. Chronic gentamicin nephrotoxicity. Continued tubular injury with preserved glomerular filtration function. , 1986, The American journal of pathology.
[44] G. Kahlmeter,et al. Aminoglycoside toxicity - a review of clinical studies published between 1975 and 1982. , 1984, The Journal of antimicrobial chemotherapy.
[45] D. Russell,et al. Clinical relevance of polyamines. , 1983, Critical reviews in clinical laboratory sciences.
[46] Jerome J. Schentag,et al. Comparative nephrotoxicity of gentamicin and tobramycin: pharmacokinetic and clinical studies in 201 patients , 1981, Antimicrobial Agents and Chemotherapy.
[47] S. Silbernagl. Renal handling of amino acids and oligopeptides. , 1981, Contributions to nephrology.
[48] M. Weiner,et al. Mechanism of cis-platinum nephrotoxicity: II. Morphologic observations. , 1980, The Journal of pharmacology and experimental therapeutics.
[49] G. Garibotto,et al. Renal metabolism of amino acids and ammonia in subjects with normal renal function and in patients with chronic renal insufficiency. , 1980, The Journal of clinical investigation.
[50] P. Doolan,et al. The renal aminoacidurias. , 1963, Clinical chemistry.